CD44v6和MMP2的同时表达预测了肺转移和骨髓瘤不良预后
Shoulei Liang1, Liang Li1, Zhiliang Guo1
1Department of orthopedic, The Second Hospital of Tangshan, No.21, Jianshe North Road, Tangshan 063000, China.
Future oncology (London, England)
|July 16, 2024
概括
CD44变体v6 (CD44v6) 和矩阵金属蛋白酶2 (MMP2) 是骨髓瘤患者的关键预后指标. 它们的综合表达预测了无转移和整体存活率,指导治疗决策.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 骨髓瘤是一种主要的骨癌,具有显著的转移潜力.
- 准确的预后标记对于指导治疗和改善患者结果至关重要.
研究的目的:
- 为了研究CD44变异v6 (CD44v6) 和矩阵金属蛋白酶2 (MMP2) 在骨髓瘤中的预后价值.
- 评估CD44v6和MMP2对患者生存和转移的联合预测能力.
主要方法:
- 使用免疫组织化学检测CD44v6和MMP2表达.
- 这项研究包括了113名手术切除初级骨髓瘤的患者.
主要成果:
- CD44v6和MMP2表达独立预测了无转移和整体存活.
- 结合的CD44v6和MMP2表达显示了对生存和转移的预测准确度的提高.
- 两种标志物表达高的患者的生存率最差,对肺转移的易感性最高.
结论:
- CD44v6和MMP2是骨髓瘤中显著的预后生物标志物.
- CD44v6和MMP2的组合为预测转移性进展和存活提供了一个精确的指标.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


